All Pharmaceutical industry articles – Page 7
View all stories with this category.
-
ReviewBitter Pills: The Global War on Counterfeit Drugs
Muhammad Zaman’s book gives an account of the challenges facing drug regulators worldwide
-
Business
Transforming PET imaging with silicon
Fuzionaire Diagnostics can add Si–18F radiolabels to a variety of molecules quickly, easily and cheaply
-
Opinion
What would a 1980s student make of modern research?
Nano- and macromolecular science might make for a shocking read in the launderette
-
Business
Lords criticise post-Brexit regulation plans
Current lack of preparedness risks ‘cliff-edge’ on exit day, committee warns
-
Opinion
Passing through checkpoints
A new breed of cancer treatments highlights what’s possible when industry concentrates its efforts
-
Business
Small biocides companies face uncertain fate
Cost and complexity of European law hampers innovation and excludes SMEs
-
Business
Cancer immunotherapy spreads rapidly
New approvals and expanded use for checkpoint inhibitor drugs illustrate the power of Nobel-winning science
-
Opinion
The projects drug companies wish they’d never started
Failures are common in drug research, but some are bigger than others
-
Research
Remote controlled self-optimising flow synthesis
Online interface could allow virtual sharing of complex kit, and enable simple improvement of reaction conditions
-
Sponsored
Continuous manufacturing could revolutionise drug development
Continuous flow manufacturing of pharmaceuticals offer the flexibility to accelerate the drug development process
-
Business
Cleaning up clinical trials
Campaigns to enforce complete and correct reporting of trial data are beginning to take hold
-
Business
Novartis to cut over 2000 jobs
Move exemplifies a wave of manufacturing cuts as pharma moves to more high-value, specialised medicines
-
Opinion
Has Crispr’s patent battle run its course?
As the originators duke it out in court, their patents are becoming increasingly irrelevant
-
Business
India moves to ban cocktail drugs
Government injunction on 328 fixed dose combinations is strongly opposed by manufacturers
-
-
Business
Landmark China cancer drug full approval ‘first of a wave’
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation
-
News
Bitter feuding at Cochrane healthcare audit body paralyses organisation
One member has been expelled from the governing board while another four resign with accusations of pharmaceutical industry bias flying
-
Business
Building resilience to climate threats
As extreme weather events become more frequent, chemical and pharmaceutical producers are taking steps to fend them off in future
-
Research
Genentech antibiotic quells resistance
Modified arylomycin combines high potency with new mechanism of action
-
Business
Europe opens gates to CAR-T
First two modified T-Cell cancer therapies approved in the EU, but prices may be prohibitive for public health systems
